SCG Cell Therapy and A*star Launch Joint Labs with Collaboration Nearing S$30 Million to Advance iPSC Technology towards Scalable GMP Manufacturing of Cellular Immunotherapies

SCG Cell Therapy and the Agency for Science, Technology and Research (A*STAR) announced the launch of joint laboratories for cellular immunotherapies. This collaboration,aims to advance the development of iPSC technology to produce novel cell therapies that meet GMP standards.